Vertebrogenic Pain Syndrome Clinical Trial
Official title:
The Effectiveness of McGill's Method in the Treatment of Vertebrogenic Algic Syndrome
| Verified date | January 2021 |
| Source | Charles University, Czech Republic |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this study is to determine the applicability of McGill ́s method to patients with diagnoses, collectively referred to as Vertebrogenic Algic syndrome, by comparing the measured data of proband with different diagnosis locations Vertebrogenic Algic syndrome in the Czech Republic.
| Status | Completed |
| Enrollment | 30 |
| Est. completion date | May 30, 2020 |
| Est. primary completion date | March 15, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 20 Years to 55 Years |
| Eligibility | Inclusion Criteria: - cervical pain syndrome - thoracic pain syndrome - lumbar pain syndrome Exclusion Criteria: - red falgs |
| Country | Name | City | State |
|---|---|---|---|
| Czechia | Charles University, Faculty of physical education and sport | Praha |
| Lead Sponsor | Collaborator |
|---|---|
| Charles University, Czech Republic |
Czechia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pain relief | change in pain perception measured on a visual analog scale - from 0 (without pain) to 10 (maximum pain) | 4 weeks, 2 times a week exercising for 60 minutes | |
| Primary | multi-segmental efficiency | comparison of the effectiveness of therapy of the three evaluated groups against each other by Short Form (SF36) Healthy survey questionnaire, the scale from 100 to 900, lower value indicate a higher effect | 4 weeks |